Re: Adjuvant Radiotherapy Versus Early Salvage Radiotherapy plus Short-term Androgen Deprivation Therapy in Men with Localised Prostate Cancer After Radical Prostatectomy (GETUG-AFU 17): A Randomised, Phase 3 Trial

被引：0
|
作者：
Rodriguez-Sanchez, Lara [1 ]
Crehangec, Gilles [3 ,4 ]
Bennamoun, Mostefa [5 ]
Macek, Petr [2 ]
Cathelineau, Xavier [2 ]
Sanchez-Salas, Rafael [2 ]
机构：
[1] Hosp Univ Miguel Servet, Dept Urol, Zaragoza, Spain
[2] Inst Mutualiste Montsouris, Dept Urol, 42 Blvd Jourdan, F-75014 Paris, France
[3] Inst Curie, Dept Radiat Oncol, Paris, France
[4] Inst Mutualiste Montsouris, Dept Radiat Oncol, Paris, France
[5] Inst Mutualiste Montsouris, Dept Med Oncol, Paris, France
来源：
EUROPEAN UROLOGY | 2021年 / 79卷 / 04期
关键词：
RISK;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：555 / 556
页数：2
相关论文
共 50 条
  • [31] Adding radiotherapy to androgen deprivation therapy in men with node-positive prostate cancer after radical prostatectomy A meta-analysis
    Guo, Lijuan
    Zhu, Zhaowei
    Zhang, Xuepei
    [J]. MEDICINE, 2020, 99 (10) : E19153
  • [32] SURVIVAL ANALYSIS OF A RANDOMIZED PHASE III TRIAL COMPARING ANDROGEN DEPRIVATION THERAPY (ADT) PLUS DOCETAXEL VERSUS ADT ALONE IN HORMONE-SENSITIVE METASTATIC PROSTATE CANCER (GETUG-AFU 15/0403)
    Gravis, G.
    Fizazi, K.
    Lobbedez, F. Joly
    Oudard, S.
    Priou, F.
    Latorzeff, I.
    Delva, R.
    Krakowski, I.
    Laguerre, B.
    Rolland, F.
    Theodore, C.
    Deplanque, G.
    Ferrero, J. M.
    Pouessel, D.
    Mourey, L.
    Beuzeboc, P.
    Zanetta, S.
    Esterni, B.
    Habibian, M.
    Soulie, M.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 294 - 294
  • [33] Re: Prostate Cancer-Specific Survival Following Salvage Radiotherapy versus Observation in Men with Biochemical Recurrence after Radical Prostatectomy
    Eastham, James Andrew
    [J]. EUROPEAN UROLOGY, 2009, 55 (01) : 247 - 247
  • [34] Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
    Gongora, Magdalena
    Stranne, Johan
    Johansson, Eva
    Bottai, Matteo
    Karlsson, Camilla Thellenberg
    Brasso, Klaus
    Hansen, Steinbjorn
    Jakobsen, Henrik
    Jaderling, Fredrik
    Lindberg, Henriette
    Lilleby, Wolfgang
    Petersen, Peter Meidahl
    Mirtti, Tuomas
    Olsson, Mats
    Rannikko, Antti
    Roder, Martin Andreas
    Vincent, Per Henrik
    Akre, Olof
    [J]. EUROPEAN UROLOGY OPEN SCIENCE, 2022, 41 : 63 - 73
  • [35] Combination of adjuvant radiotherapy and androgen deprivation therapy after radical prostatectomy in high risk prostate cancer patients - results from retrospective analysis
    Omrcen, Tomislav
    Hrepic, Dario
    Jelavic, Tihana Boraska
    Vrdoljak, Eduard
    [J]. JOURNAL OF BUON, 2015, 20 (04): : 1061 - 1067
  • [36] Salvage Radiotherapy Versus Hormone Therapy for Prostate -specific Antigen Failure After Radical Prostatectomy: A Randomised, Multicentre, Open -label, Phase 3 Trial (JCOG0401)
    Yokomizo, Akira
    Wakabayashi, Masashi
    Satoh, Takefumi
    Hashine, Katsuyoshi
    Inoue, Takahiro
    Fujimoto, Kiyohide
    Egawa, Shin
    Habuchi, Tomonori
    Kawashima, Kiyotaka
    Ishizuka, Osamu
    Shinohara, Nobuo
    Sugimoto, Mikio
    Yoshino, Yasushi
    Nihei, Keiji
    Fukuda, Haruhiko
    Tobisu, Ken-ichi
    Kakehi, Yoshiyuki
    Naito, Seiji
    [J]. EUROPEAN UROLOGY, 2020, 77 (06) : 689 - 698
  • [37] Addition of Radiotherapy to Long-Term Androgen Deprivation in Locally Advanced Prostate Cancer: An Open Randomised Phase 3 Trial
    Mottet, Nicolas
    Peneau, Michel
    Mazeron, Jean-Jacques
    Molinie, Vincent
    Richaud, Pierre
    [J]. EUROPEAN UROLOGY, 2012, 62 (02) : 213 - 219
  • [38] Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): an open-label, randomised, phase 3 factorial trial
    Denham, James W.
    Joseph, David
    Lamb, David S.
    Spry, Nigel A.
    Duchesne, Gillian
    Matthews, John
    Atkinson, Chris
    Tai, Keen-Hun
    Christie, David
    Kenny, Lizbeth
    Turner, Sandra
    Gogna, Nirdosh Kumar
    Diamond, Terry
    Delahunt, Brett
    Oldmeadow, Christopher
    Attia, John
    Steigler, Allison
    [J]. LANCET ONCOLOGY, 2014, 15 (10): : 1076 - 1089
  • [39] Phase 2, multicenter, randomized study of salvage radiation therapy plus /- metformin for recurrent prostate cancer after radical prostatectomy (SAKK 08/15-GETUG-AFU 34 PROMET trial).
    Dal Pra, Alan
    Supiot, Stephane
    Gysel, Katrin
    Zilli, Thomas
    Cathomas, Richard
    Reynaud, Thomas
    Pommier, Pascal
    Putora, Paul Martin
    Bosetti, Davide Giovanni
    Guckenberger, Matthias
    Hildebrandt, Guido
    Chiquet, Sabrina
    Brihoum, Meryem
    Papachristofilou, Alexandros
    Hayoz, Stefanie
    Ghadjar, Pirus
    Zwahlen, Daniel Rudolf
    Gillessen, Silke
    Omlin, Aurelius Gabriel
    Aebersold, Daniel M.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [40] A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24
    Gonzalez-San Segundo, Carmen
    Campos, Fernando Lopez
    Gomez Iturriaga, Alfonso
    Rodriguez, Aurora
    Olivera, Jesus
    Duque-Santana, Victor
    Sancho, Gemma
    Henriquez, Ivan
    Conde, Antonio Jose
    Valero, Jeannette
    Maldonado, Xavier
    Glaria, Luis
    Caballero, Begona
    Sanmamed, Noelia
    Mases, Joel
    Boladeras-Inglada, Anna Maria
    Montijano, Miguel
    Santos, Marina
    Alvarez, Ana
    Martinez, Juan I.
    Counago, Felipe
    [J]. BJU INTERNATIONAL, 2024,
12345